Latest News about Gilead Sciences Inc
Recent news which mentions Gilead Sciences Inc
Trump's drug price ultimatum sets pharma firms scrambling
August 01, 2025
From CNBC.com News
From CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
July 08, 2025
From CNBC.com News
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
June 18, 2025
From CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
June 17, 2025
From CNBC.com News
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
June 03, 2025
From CNBC.com News
Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know
May 12, 2025
From CNBC.com News
Corporate America shelled out millions for Trump's inauguration. Now he's upending many of their businesses
April 23, 2025
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
From CNBC.com News
U.S. investors, Big Pharma race to find new medicines in China
February 13, 2025
From CNBC.com News
Salesforce picks board member Robin Washington to be its next finance and operating leader
February 05, 2025
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
November 07, 2024
From CNBC.com News
5 things to know before the stock market opens Friday
September 13, 2024
From CNBC.com News
Gilead's twice-yearly shot cut HIV infections by 96% in trial
September 12, 2024
From CNBC.com News
Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuit
August 16, 2024
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
From CNBC.com News
5 things to know before the stock market opens Friday
June 21, 2024
From CNBC.com News
From CNBC.com News
From Business Journals
From Business Journals
Gilead stock falls after disappointing lung cancer study results
January 22, 2024
From CNBC.com News
Fraud in a bottle: How Big Pharma takes on criminals who make millions off counterfeit drugs
December 11, 2023
From CNBC.com News
Miami man pleads guilty to selling adulterated, misbranded HIV drugs across United States
September 26, 2023
From CNBC.com News
Stocks making the biggest moves midday: Kroger, DocuSign, Planet Labs, First Solar and more
September 08, 2023
Tickers
RH
From CNBC.com News
Stocks making the biggest moves before the bell: Kroger, DocuSign, Snowflake, Adobe and more
September 08, 2023
Tickers
RH
From CNBC.com News
Stocks making the biggest moves midday: AMC Entertainment, Mattel, Chevron, Spotify and more
July 24, 2023
From CNBC.com News
Hepatitis C cure is not reaching overwhelming majority of patients due to financial barriers
June 29, 2023
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.